Jared Barsky
Examiner (ID: 13656)
Most Active Art Unit | 1628 |
Art Unit(s) | 1628 |
Total Applications | 196 |
Issued Applications | 132 |
Pending Applications | 0 |
Abandoned Applications | 64 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18449538
[patent_doc_number] => 20230190814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/166447
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166447
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166447 | METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY | Feb 7, 2023 | Pending |
Array
(
[id] => 17805842
[patent_doc_number] => 20220257677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS
[patent_app_type] => utility
[patent_app_number] => 17/707951
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/707951 | ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS | Mar 29, 2022 | Pending |
Array
(
[id] => 17718299
[patent_doc_number] => 20220211018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => MULTI-TRANSGENIC PIGS WITH GROWTH HORMONE RECEPTOR KNOCKOUT FOR XENOTRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 17/531416
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531416 | MULTI-TRANSGENIC PIGS WITH GROWTH HORMONE RECEPTOR KNOCKOUT FOR XENOTRANSPLANTATION | Nov 18, 2021 | Pending |
Array
(
[id] => 17627539
[patent_doc_number] => 20220162554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => MODIFIED T CELLS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/525644
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525644
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525644 | MODIFIED T CELLS AND METHODS OF MAKING AND USING THE SAME | Nov 11, 2021 | Pending |
Array
(
[id] => 18398221
[patent_doc_number] => 11660337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus
[patent_app_type] => utility
[patent_app_number] => 17/502116
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 16558
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502116 | Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus | Oct 14, 2021 | Issued |
Array
(
[id] => 17548169
[patent_doc_number] => 20220119510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => ANTI-POLYETHYLENE GLYCOL (PEG) ANTIBODY MOUSE MODEL FOR RIGOROUS ASSESSMENT OF PEG-BASED THERAPIES: ADJUVANT-FREE INDUCTION MODEL
[patent_app_type] => utility
[patent_app_number] => 17/503057
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503057
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503057 | ANTI-POLYETHYLENE GLYCOL (PEG) ANTIBODY MOUSE MODEL FOR RIGOROUS ASSESSMENT OF PEG-BASED THERAPIES: ADJUVANT-FREE INDUCTION MODEL | Oct 14, 2021 | Pending |
Array
(
[id] => 18675128
[patent_doc_number] => 20230312713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => In vivo targeting of T cells for mRNA therapeutics
[patent_app_type] => utility
[patent_app_number] => 17/906781
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906781 | In vivo targeting of T cells for mRNA therapeutics | Oct 12, 2021 | Pending |
Array
(
[id] => 17561694
[patent_doc_number] => 20220125843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => MODIFIED CELLS AND METHODS OF THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/478615
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478615 | MODIFIED CELLS AND METHODS OF THERAPY | Sep 16, 2021 | Pending |
Array
(
[id] => 17556084
[patent_doc_number] => 11312760
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-04-26
[patent_title] => Expression vector for anti-SARS-CoV-2 neutralizing antibodies
[patent_app_type] => utility
[patent_app_number] => 17/391262
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 20454
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/391262 | Expression vector for anti-SARS-CoV-2 neutralizing antibodies | Aug 1, 2021 | Issued |
Array
(
[id] => 17292225
[patent_doc_number] => 20210388064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => ADENO-ASSOCIATED VIRUS ANTIBODIES AND FRAGMENTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/348356
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348356 | ADENO-ASSOCIATED VIRUS ANTIBODIES AND FRAGMENTS THEREOF | Jun 14, 2021 | Pending |
Array
(
[id] => 17299931
[patent_doc_number] => 20210395770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Muscle-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/343563
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/343563 | Muscle-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof | Jun 8, 2021 | Pending |
Array
(
[id] => 17428408
[patent_doc_number] => 20220056116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 17/318316
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318316 | Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer | May 11, 2021 | Pending |
Array
(
[id] => 17255767
[patent_doc_number] => 20210368752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => Genetically Modified Non-Human Animals And Methods Of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/316266
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/316266 | Genetically Modified Non-Human Animals And Methods Of Use Thereof | May 9, 2021 | Pending |
Array
(
[id] => 17034243
[patent_doc_number] => 20210251201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE
[patent_app_type] => utility
[patent_app_number] => 17/241171
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/241171 | NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE | Apr 26, 2021 | Pending |
Array
(
[id] => 17052522
[patent_doc_number] => 20210261956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => Gene Editing to Improve Joint Function
[patent_app_type] => utility
[patent_app_number] => 17/241839
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241839
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/241839 | Gene Editing to Improve Joint Function | Apr 26, 2021 | Pending |
Array
(
[id] => 17154138
[patent_doc_number] => 20210315189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => MICE EXPRESSING A LIMITED IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE
[patent_app_type] => utility
[patent_app_number] => 17/238710
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17238710
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/238710 | MICE EXPRESSING A LIMITED IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE | Apr 22, 2021 | Pending |
Array
(
[id] => 17183820
[patent_doc_number] => 20210330705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => TOLEROGENIC DENDRITIC CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/237475
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237475 | TOLEROGENIC DENDRITIC CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME | Apr 21, 2021 | Pending |
Array
(
[id] => 16945840
[patent_doc_number] => 20210204531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => COMMON LIGHT CHAIN MOUSE
[patent_app_type] => utility
[patent_app_number] => 17/209964
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209964
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209964 | COMMON LIGHT CHAIN MOUSE | Mar 22, 2021 | Pending |
Array
(
[id] => 17082111
[patent_doc_number] => 20210277117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CONSTRUCTS TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/203665
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203665
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203665 | CONSTRUCTS TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF | Mar 15, 2021 | Abandoned |
Array
(
[id] => 17123509
[patent_doc_number] => 20210298277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => HUMAN ARTIFICIAL CHROMOSOME CONTAINING HUMAN ANTIBODY LAMBDA LIGHT CHAIN GENE AND NON-HUMAN ANIMAL CONTAINING THE HUMAN ARTIFICIAL CHROMOSOME CAPABLE OF GENETIC TRANSMISSION
[patent_app_type] => utility
[patent_app_number] => 17/196608
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17196608
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/196608 | HUMAN ARTIFICIAL CHROMOSOME CONTAINING HUMAN ANTIBODY LAMBDA LIGHT CHAIN GENE AND NON-HUMAN ANIMAL CONTAINING THE HUMAN ARTIFICIAL CHROMOSOME CAPABLE OF GENETIC TRANSMISSION | Mar 8, 2021 | Pending |